Table of Contents Author Guidelines Submit a Manuscript
International Journal of Pediatrics
Volume 2011 (2011), Article ID 470364, 4 pages
http://dx.doi.org/10.1155/2011/470364
Clinical Study

An Evaluation of Initial Vancomycin Dosing in Infants, Children, and Adolescents

1Department of Pharmacy, Moses H. Cone Memorial Hospital, Greensboro, NC 27401, USA
2Department of Pharmacy, Moses H. Cone Memorial Hospital, 1200 North Elm Street, Greensboro, NC 27401-1020, USA

Received 14 July 2011; Accepted 9 August 2011

Academic Editor: Hans Juergen Laws

Copyright © 2011 Laura Broome and Tsz-Yin So. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Vancomycin, [Lexi-Comp ONLINE web site], http://crlonline.com, Accessed September 25, 2010.
  2. Vancomycin, [NeoFax web site], http://neofax.thomsonhc.com/neofax, Accessed September 25, 2010.
  3. M. L. Glover, E. Cole, and J. Wolfsdorf, “Vancomycin dosage requirements among pediatric intensive care unit patients with normal renal function,” Journal of Critical Care, vol. 15, no. 1, pp. 1–4, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. K. W. Benner, M. A. Worthington, D. W. Kimberlin et al., “Correlation of vancomycin dosing to serum concentrations in pediatric patients: a retrospective database review,” Journal of Pediatric Pharmacology and Therapeutics, vol. 14, pp. 86–93, 2009. View at Google Scholar
  5. The Columbia Encyclopedia, “6th Ed. [The Columbia Encyclopedia web site],” http://www.encyclopedia.com/, Accessed September 25, 2010.
  6. M. Rybak, B. Lomaestro, J. C. Rotschafer et al., “Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists,” American Journal of Health-System Pharmacy, vol. 66, no. 1, pp. 82–98, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. M. J. Rybak, L. M. Albrecht, S. C. Boike, and P. H. Chandrasekar, “Nephrotoxicity of vancomycin, alone and with an aminoglycoside,” Journal of Antimicrobial Chemotherapy, vol. 25, no. 4, pp. 679–687, 1990. View at Google Scholar · View at Scopus
  8. L. S. Eiland, T. M. English, and E. H. Eiland III., “Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients,” Annals of Pharmacotherapy, vol. 45, no. 5, pp. 582–589, 2011. View at Publisher · View at Google Scholar · View at PubMed
  9. K. J. Welsh, A. N. Abbott, E. M. Lewis et al., “Clinical characteristics, outcomes, and microbiologic features associated with methicillin-resistant Staphylococcus aureus bacteremia in pediatric patients treated with vancomycin,” Journal of Clinical Microbiology, vol. 48, no. 3, pp. 894–899, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. E. Chiappini, C. Conti, L. Galli, and M. de Martino, “Clinical efficacy and tolerability of linezolid in pediatric patients: a systematic review,” Clinical Therapeutics, vol. 32, no. 1, pp. 66–88, 2010. View at Google Scholar · View at Scopus
  11. J. Dotis, E. Iosifidis, M. Ioannidou, and E. Roilides, “Use of linezolid in pediatrics: a critical review,” International Journal of Infectious Diseases, vol. 14, no. 8, pp. e638–e648, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. S. Garazzino, A. Krzysztofiak, S. Esposito et al., “Use of linezolid in infants and children: a retrospective multicentre study of the Italian society for paediatric infectious diseases,” Journal of Antimicrobial Chemotherapy, vol. 66, no. 10, pp. 2393–2397, 2011. View at Publisher · View at Google Scholar · View at PubMed